| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/01/1995 | EP0635998A1 Method and composition for inhibition of viral replication |
| 02/01/1995 | EP0535150B1 Human macrophage inflammatory protein 2-beta |
| 02/01/1995 | EP0500736B1 Recombinant vaccine for porcine pleuropneumonia |
| 02/01/1995 | CN1098140A Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 01/31/1995 | US5386331 Load beam and flexure assembly having flexible arms with specific width ratios |
| 01/31/1995 | US5386025 Calcium channel compositions and methods |
| 01/31/1995 | US5386024 Method to prepare nucleic acids from a biological sample using low pH and acid protease |
| 01/31/1995 | US5386022 Primes and probes for the amplification and detection of aids associated nucleic acids |
| 01/31/1995 | US5386021 Mammalian guanine nucleotide binding protein with an ADP-rybosylation factor domain |
| 01/31/1995 | US5386020 Branched oligonucloetides having double-stranded projections bonded to each other to yield frame for use in immobilizing other macromolecules |
| 01/31/1995 | US5385841 Increase production of extracellular enzyme or heterologous polypeptides |
| 01/31/1995 | US5385840 Respiratory system |
| 01/31/1995 | US5385839 Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter regulatory DNA sequence |
| 01/31/1995 | US5385834 Mutant T7 RNA polymerase GP1(lys222) exhibiting altered promoter recognition |
| 01/31/1995 | US5385732 Variants of tissue plasminogen activator, compositions and methods of use for same |
| 01/31/1995 | CA2129156A1 High level expression of polypeptide that contains modified pres1 region of hepatitis b virus large antigen |
| 01/31/1995 | CA1334177C Production of chimeric antibodies by homologous recombination |
| 01/31/1995 | CA1334176C Monoclonal antibody recognizing gamma atrial natriuretic polypeptide |
| 01/31/1995 | CA1334175C Plant promoter and method for using same |
| 01/30/1995 | CA2126523A1 Jak kinases and regulation of cytokine signal transduction |
| 01/27/1995 | CA2128653A1 Nucleotide sequences allowing the replication and conservation of a genetic information in animal cells |
| 01/26/1995 | WO1995002823A1 Identification of ligands by selective amplification of cells transfected with receptors |
| 01/26/1995 | WO1995002751A1 Method for repairing a combustion chamber assembly |
| 01/26/1995 | WO1995002704A2 Poliovirus specific primers and methods of detection utilizing the same |
| 01/26/1995 | WO1995002701A1 Method of identifying human and animal cells capable of unlimited proliferation or tumour formation |
| 01/26/1995 | WO1995002698A1 Composition and methods for transfecting eukaryotic cells |
| 01/26/1995 | WO1995002697A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/26/1995 | WO1995002696A1 Fruit specific promoters |
| 01/26/1995 | WO1995002695A1 Formation of and methods for the production of large bacillus thuringiensis crystals with increased pesticidal activity |
| 01/26/1995 | WO1995002694A2 Materials and methods for the control of calliphoridae pests |
| 01/26/1995 | WO1995002693A1 Bacillus thuringiensis isolates and toxins |
| 01/26/1995 | WO1995002692A1 Modified alpha-lactalbumin |
| 01/26/1995 | WO1995002691A2 Production and application of transgenic mushroom mycelium and fruitbodies |
| 01/26/1995 | WO1995002690A1 Nucleotide sequences and process for amplifying and detection of hepatitis b virus |
| 01/26/1995 | WO1995002689A1 An enzyme with acetyl esterase activity |
| 01/26/1995 | WO1995002687A1 Immortalized human fetal osteoblastic cells |
| 01/26/1995 | WO1995002686A1 Redirection of cellular immunity by receptor chimeras |
| 01/26/1995 | WO1995002684A1 Regulated apoptosis |
| 01/26/1995 | WO1995002683A1 Method of synthesizing saccharide compositions |
| 01/26/1995 | WO1995002675A1 A detergent composition comprising two cellulase components |
| 01/26/1995 | WO1995002612A1 Monoclonal antibodies to egg yolk immunoglobulins (igy) |
| 01/26/1995 | WO1995002421A1 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
| 01/26/1995 | WO1995002397A1 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 01/26/1995 | WO1995002319A1 Transgenic plants containing multiple disease resistance genes |
| 01/26/1995 | WO1994028146A3 Dna sequences and plasmids for the preparation of sugar beet with changed sucrose concentration |
| 01/26/1995 | WO1994028126A3 Phenylalanine-free protein and dna coding therefor |
| 01/26/1995 | WO1994028125A3 Dna encoding prostaglandin receptor ep1 |
| 01/26/1995 | WO1994028014A3 Peptide inhibitors of urokinase receptor activity |
| 01/26/1995 | WO1994026934A3 Human papillomavirus detection assay |
| 01/26/1995 | WO1994024559A3 Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases |
| 01/26/1995 | DE4412629A1 Nucleic acid transfer peptides and their use for including nucleic acids in eucaryotic cells |
| 01/26/1995 | CA2167282A1 Regulated apoptosis |
| 01/26/1995 | CA2167209A1 Poliovirus specific primers and method of detection utilizing the same |
| 01/26/1995 | CA2167157A1 Method of synthesizing saccharide compositions |
| 01/26/1995 | CA2167155A1 Modified alpha-lactalbumin |
| 01/26/1995 | CA2167152A1 Production and application of transgenic mushroom mycelium and fruitbodies |
| 01/26/1995 | CA2167056A1 Nucleotide sequences and process for amplifying and detection of hepatitis b virus |
| 01/26/1995 | CA2166976A1 Method for identifying human and animal cells having an unlimited proliferation or tumor-formation potential |
| 01/26/1995 | CA2166875A1 Transferrin receptor specific ligand-neuro-pharmaceutical agent fusion proteins |
| 01/26/1995 | CA2166711A1 Bacillus thuringiensis isolates and toxins |
| 01/26/1995 | CA2166682A1 A detergent composition comprising two cellulase components |
| 01/26/1995 | CA2166405A1 Transgenic plants containing multiple disease resistance genes |
| 01/26/1995 | CA2144040A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/25/1995 | EP0635575A1 Monoclonal antibodies against epitopes found in free but not in alpha-1-antichmotrypsin complexed prostate specific antigen |
| 01/25/1995 | EP0635574A1 Selection marker gene free recombinant strains, a method for obtaining them and the use of these strains |
| 01/25/1995 | EP0635573A2 Process for the preparation of native human glicentin |
| 01/25/1995 | EP0635572A2 Biotin biosynthesis in bacillus subtilis |
| 01/25/1995 | EP0635069A1 Probe method and composition for detecting different dna sequences. |
| 01/25/1995 | EP0635068A1 Amplification of human mdm2 gene in human tumors |
| 01/25/1995 | EP0635067A1 Probes for detecting common liveborn chromosomal aneuploidies |
| 01/25/1995 | EP0635066A1 Quantitative viral assay |
| 01/25/1995 | EP0635065A1 Method of sequencing |
| 01/25/1995 | EP0635064A1 Gustducin materials and methods |
| 01/25/1995 | EP0635062A1 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF mRNA |
| 01/25/1995 | EP0635061A1 A method of limiting the survival of genetically engineered microorganisms in their environment |
| 01/25/1995 | EP0635060A1 Myogenic vector systems |
| 01/25/1995 | EP0635059A1 Polysaccharide binding fusion proteins and conjugates |
| 01/25/1995 | EP0635058A1 Protease vaccine against heartworm |
| 01/25/1995 | EP0635057A1 Methods for producing substantially pure eg iii cellulase using polyethylene glycol |
| 01/25/1995 | EP0635056A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor |
| 01/25/1995 | EP0635055A1 $i(HAEMOPHILUS SOMNUS) IMMUNOGENIC PROTEINS |
| 01/25/1995 | EP0635054A1 Mammalian melanocyte stimulating hormone receptors and uses |
| 01/25/1995 | EP0635053A1 A novel enzyme and a dna sequence |
| 01/25/1995 | EP0635051A1 Increasing the trehalose content of organisms by transforming them with combinations of the structural genes for trehalose synthase |
| 01/25/1995 | EP0635030A1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/$i(neu)) RELATED SURFACE ANTIGENS |
| 01/25/1995 | EP0635029A1 Cartilage matrix protein and methods for use |
| 01/25/1995 | EP0635023A1 Covalently cross-linked oligonucleotides |
| 01/25/1995 | EP0634938A1 Immunotoxins directed against cd33 related surface antigens |
| 01/25/1995 | EP0634936A1 Materials and methods for immunocontraception |
| 01/25/1995 | EP0634896A1 Evaluation and treatment of patients with progressive immunosuppression |
| 01/25/1995 | EP0538461A4 Transgenic plants with altered polyol content |
| 01/25/1995 | EP0429490B1 Aspartic proteinase deficient filamentous fungi |
| 01/24/1995 | US5384259 Construct and method for expression of tetracycline resistance genes in E. Coli |
| 01/24/1995 | US5384258 Bacillus stearothermophilus and E. coli plasmids |
| 01/24/1995 | US5384257 Glucose isomerases with an altered pH optimum |
| 01/24/1995 | US5384255 Ubiquitin carrier enzyme E2-F1, purification, production, and use |
| 01/24/1995 | US5384253 Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes |
| 01/24/1995 | US5384250 Prokaryotic cells |
| 01/24/1995 | US5384249 Adding sialic acid to glycoproteins and glycolipids |
| 01/24/1995 | US5384122 Herpesvirus particles and vaccine |